locally generated ANG II for cardiovascular homeostasis is clear. Previously, ANG II release from isolated rat mesenteric artery preparation has been reported to be enhanced by sympathetic nerve stimulation and a sympathomimetic drug (Nakamaru et al., 1986) , and ANG I generation is increased by renin substrate added to the hindquarter perfusion (Oliver and Sciacca, 1984) . More directly, angiotensins have been shown to be synthesized and secreted in cultured bovine aortic endothelial cells (Kifor and Dzau, 1987) . These findings and the recently recognized tissue-specific angiotensinogen mRNA (Ohkubo et al., 1986; Kalinyak and Perlman, 1987) sug gest the possibility that renal and local RAS may be independently regulated. The present study was undertaken to elucidate the relationship between renal and vascular RAS, using ex vivo perfusion of the mesenteric arteries in rats with various renin levels in the circulation. Furthermore, in order to assess whether vascular RAS play a role in the hypotensive effect of angiotensin converting enzyme (ACE) inhibitors, we attempted to study the effects of captopril on vascular ANG II generation in rats. 9:00 to 20:30. All animals were fed normal rat chow (CRF-l, Charles River, U.S.A.) which contained 0.012 m mol/g of sodium, 0.224 m mol/ g of potassium and 0.3 m mol/g of calcium for one week prior to the experiment. All rats were allowed to drink water ad libitum and were randomly allocated into four groups. Ten animals constituted each group. Silastic rubber strips impregnated with DOCA (Sigma Chemicals Co. St. Louis, U.S.A.) or dexamethasone (Wako Chemicals Co. Osaka, Japan) were prepared according to the method of Berecek and Bohr (1977) as reported previously (Miyamori et al., 1985) . Silastic rubber strips containing no drugs were given to the two groups of rats which were allowed free access to tap water: one group served as the control, and the other group received total nephrectomy 72 hours prior to the perfusion study. DOCA was given at a dose of 50 mg/kg and these animals were given a 1% NaC1 solution to drink for 28 days. For the treatment with glucocorticoid, the animals Results Table 1 shows the body weight, blood pressure (BP), heart rate, PRA and plasma ANG II concentrations in the four groups of rats. Approximately half of the rats in each group were given captopril.
In nephrectomized rats, the basal plasma ANG II and PRA decreased, the latter to an undetectable level. In the DOCA/salt treated rats, PRA and ANG II were markedly suppressed but were still measurable, and BP and body weight were higher than in the control rats. In dexamethasone treated rats also, the BP rose but the PRA and plasma ANG II levels were markedly higher than in the three other groups of rats. There was no significant difference in heart rate among the four groups of rats.
Captopril administration induced a slight but significant decrease in BP in the control, nephrectomized and dexamethasone treated rats. In the DOCA/salt treated rats, BP was not significantly influenced by oral captopril administration.
The heart rate decreased signicantly in the nephrectomized rats in response to captopril (Figure 1 ). In the nephrectomized rats and in DOCA/salt rats, PRA did not change with captopril administration. 0.01). Basal ANG II output in the DOCA/ salt rats and dexamethasone treated rats was 12.8+ 7.1 pg/h and 6.9pg/h, respectively which was significantly lower than control and nephrectomized rats (P<0.01). Captopril administration changed ANG II output to 11.7+0.7 pg/h and 4.7+1.3 pg/h in DOCA/salt and dexamethasone rats, respectively.
Discussion
It has previously been shown that ANG II is continuously produced in the mesenteric and hindlimb preparations, and it has been suggested that it plays a role in the local regulation of vascular tone (Dzau, 1986) . The present study confirmed arterial release of ANG II in the rat mesenteric artery, and further demonstrated that this release is augmented by nephrectomy, suggesting that the renal and vascular RAS may be under independent regulation.
The mechanism of increased vascular ANG II generation produced by nephrectomy is not evident from the present study. It may be postulated first that the circulating ANG II is negatively related to the RAS in the vascular tissue. Thus, a release from the negative feedback by the RAS in the circulation after nephrectomy could explain the increase in vascular ANG II production.
However, the decreased vascular ANG II production in DOCA salt rats, in which the plasma renin level is supressed by expanded plasma volume, makes the above possibility less likely. Secondly, the potassium ions accumulated following nephrectomy may stimulate vascular renin production as demonstrated in adrenal renin which is increased after potassium loading in the presence of a suppressed plasma renin level (Nakamaru et al., 1985) . Thirdly, a role of the sympathetic nerve activation in the stimulation of vascular ANG II generation (Nakamura et al., 1986) following nephrectomy has yet to be proven.
It may be argued that ANG II released in the perfusate would originate from the circulation which was bound to the endothelium. In the present study the ANG II concentration in the fractionated perfusion samples showed no time-dependent decline up to 120 min, supporting the view that it reflects in part newly synthesized ANG II locally. More directly, the cellular synthesis and secretion of ANG II and ANG III has been reported in cultured bovine aortic endothelial cells (Kifor et al., 1987) .
The physiological significance of the RAS locally generated in the vascular wall is not well understood. It is hypothesized that the system may play a role in the maintenance of vascular tone (Oliver and Siacca, 1984; Zau 1986 ) and blood pressure regulation (Thurston et al., 1979; Loundon et al., 1983; Okamura et al., 1986) in hypertensive animal models, either directly or indirectly by facilitating sympathetic nerve transmission (Ziogas et al., 1985; Malik et al., 1976) .
Although it is now evident that peripheral tissues produce angiotensins and only a portion of the plasma concentration is produced by the renal RAS (Dzau, 1986; Campbell, 1985) , it is not clear from this study to what extent vascular ANG II contributes to the plasma concentration.
Thus, vascular RAS activity appears unrelated to the plasma level. In fact, an increased aortic renin-like activity in the presence of a normal or decreased circulating renin level is reported in spontaneously hypertensive rats (Assad and Antonaccio, 1982) and the chronic phase of Goldblatt twokidney hypertension rats (Garst et al., 1979) . This dissociation of the local and circulating RAS suggests that the local RAS may contribute little to the circulating RAS level. However, few studies have been reported which directly tested the vascular ANG II generation in various experimental hypertensive models.
In DOCA salt rats, the sympathetic tone is activated (Reid et al., 1975) and this may facilitate ANG II formation (Nakamura et al., 1986) . ANG II generated in the arterial wall is therefore felt to be increased in this model. In the present study, however, ANG II release from the mesenteric artery are suppressed in DOCA/ salt rats.
Therefore, it is unlikely that vascular RAS activation may participate in the pathogenesis of hypertension in this model. In keeping with this finding, there is also evidence that aortic renin is decreased in DOCA salt rats . It is speculated that a common mechanism of RAS regulation such as expanded plasma volume, in kidneys and vessels may be operative in DOCA salt rats.
In glucocorticoid hypertensive rats, the RAS is increased in the circulation and suppressed in the vascular wall. Tissuespecific angiotensinogen mRNA has recently been demonstrated to be expressed in various tissues, e.g., liver, mesentery, aorta, atria, kidney, brain, spinal cord, large intestine, adrenal, and lung (Ohkubo et al., 1986) . Glucocorticoid administration has been reported to increase the accumulation of angiotensinogen mRNA in the liver and the kidney (Kalinyak et al., 1987) .
In another study, coadministration of dexamethasone, estradiol and triiodothyronine accumulated mRNA in several tissues including the mesentery (Campbell and Habener 1986 (Suzuki et al., 1988) . These authors explained the dissociation of mRNA and its related product by differences in translational efficiency among various organs, or differences in post-translational processing.
It is not known whether the differences in processing could result in the altered renal and vascular angiotensinogen level in response to dexamethasone administration in rats.
Captopril administration decreased BP which was not associated with changes in mesenteric ANG II production in glucocorticoid treated rats. The hypotensive effect of captopril is most likely achieved by reducing the circulating ANG II in this model of hypertension.
Although the ex vivo perfusion pressure observed in the above experiments may not be synonymous with the vascular tone in vivo, vasoconstrictors added to the perfusion circuit respond similarly to changes observed in vivo. Lastly, the possibility of ANG III formation as a consequence of the elimination of of the aminoterminal aspertyl residue of ANG II, intracellulary or after secretion, might account for the apparently small amount of ANG II in the effluent. In the present assay system, however, ANG II and ANG III were not distinguishable. Taken together the results support a minor contribution of the locally released angiotensins in the circulation. We also speculate that in certain pathophysiological conditions, the local RAS may be important as an autocrine or paracrine for the control of vascular tone as suggested previously (Dzau 1984) .
